Clinical Trial

Health eHeart BioBank

Study acronym: HeH BioBank
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of the Health eHeart BioBank is to collect and store specimen (e.g. blood, DNA, tissue) for future studies at the University of California, San Francisco (UCSF) that will help determine changes and identify molecular and genetic markers in the human body that might help increase our knowledge of heart disease and guide development of new diagnostic tools and treatments that may help rapidly detect heart disease and prevent and/or treat heart disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-08; most recent amendment 2026-07-13.
Status change: Recruiting → Enrolling by Invitation 2025-06-05
Trial Details
NCT Number NCT06976502
Lead Sponsor University of California, San Francisco
Conditions Heart Diseases, Cardiac Diseases, Vascular Diseases, Cardiovascular Diseases
Enrollment 500,000 participants
Start Date 2025-04-01
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-14